Search research articles
Contact Us
Filters
Showing results (191-200 of 262) with videos related to
Page
of 27
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 28, 2015
BEYOND: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase III Study of First-Line Carboplatin/Paclitaxel Plus Bevacizumab or Placebo in Chinese Patients With Advanced or Recurrent Nonsquamous Non-Small-Cell Lung Cancer
Caicun Zhou, Yi-Long Wu, Gongyan Chen, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
November 27, 2013
Aprepitant triple therapy for the prevention of chemotherapy-induced nausea and vomiting following high-dose cisplatin in Chinese patients: a randomized, double-blind, placebo-controlled phase III trial
Zhihuang Hu, Ying Cheng, Hongyu Zhang, et al.
Future Oncology (London, England)
|
February 10, 2021
Quality-adjusted survival in patients with metastatic colorectal cancer treated with fruquintinib in the FRESCO trial
Shukui Qin, Jin Li, Yuxian Bai, et al.
BMC Cancer
|
February 7, 2023
Safety and efficacy of Pucotenlimab (HX008) - a humanized immunoglobulin G4 monoclonal antibody in patients with locally advanced or metastatic melanoma: a single-arm, multicenter, phase II study
Chuanliang Cui, Yu Chen, Zhiguo Luo, et al.
British Journal of Cancer
|
May 11, 2021
Randomised Phase 1b/2 trial of tepotinib vs sorafenib in Asian patients with advanced hepatocellular carcinoma with MET overexpression
Baek-Yeol Ryoo, Ann-Li Cheng, Zhenggang Ren, et al.
Clinical and Translational Science
|
November 29, 2024
Pharmacokinetics of infigratinib and its active metabolites in Chinese patients with advanced gastric cancer harboring FGFR2 gene amplification
Jiajia Yuan, Lin Shen, Tian Shu Liu, et al.
Journal for Immunotherapy of Cancer
|
February 22, 2023
SAFFRON-103: a phase 1b study of the safety and efficacy of sitravatinib combined with tislelizumab in patients with locally advanced or metastatic non-small cell lung cancer
Jun Zhao, Xinmin Yu, Dingzhi Huang, et al.
Plos One
|
May 23, 2014
Use of metformin alone is not associated with survival outcomes of colorectal cancer cell but AMPK activator AICAR sensitizes anticancer effect of 5-fluorouracil through AMPK activation
Xinbing Sui, Yinghua Xu, Jie Yang, et al.
Cancer
|
May 30, 2025
Tebotelimab plus niraparib in previously treated locally advanced or metastatic solid tumors: A phase 1b dose escalation and expansion study
Miao-Zhen Qiu, Hongming Pan, Ka On Lam, et al.
Translational Oncology
|
April 14, 2019
A Phase Ib Study of Pembrolizumab as Second-Line Therapy for Chinese Patients With Advanced or Metastatic Melanoma (KEYNOTE-151)
Lu Si, Xiaoshi Zhang, Yongqian Shu, et al.
Page
of 27
Search research articles
Search
Showing results (191-200 of 262) with videos related to
Sort By:
Page
of 27
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 28, 2015
BEYOND: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase III Study of First-Line Carboplatin/Paclitaxel Plus Bevacizumab or Placebo in Chinese Patients With Advanced or Recurrent Nonsquamous Non-Small-Cell Lung Cancer
Caicun Zhou, Yi-Long Wu, Gongyan Chen, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
November 27, 2013
Aprepitant triple therapy for the prevention of chemotherapy-induced nausea and vomiting following high-dose cisplatin in Chinese patients: a randomized, double-blind, placebo-controlled phase III trial
Zhihuang Hu, Ying Cheng, Hongyu Zhang, et al.
Future Oncology (London, England)
|
February 10, 2021
Quality-adjusted survival in patients with metastatic colorectal cancer treated with fruquintinib in the FRESCO trial
Shukui Qin, Jin Li, Yuxian Bai, et al.
BMC Cancer
|
February 7, 2023
Safety and efficacy of Pucotenlimab (HX008) - a humanized immunoglobulin G4 monoclonal antibody in patients with locally advanced or metastatic melanoma: a single-arm, multicenter, phase II study
Chuanliang Cui, Yu Chen, Zhiguo Luo, et al.
British Journal of Cancer
|
May 11, 2021
Randomised Phase 1b/2 trial of tepotinib vs sorafenib in Asian patients with advanced hepatocellular carcinoma with MET overexpression
Baek-Yeol Ryoo, Ann-Li Cheng, Zhenggang Ren, et al.
Clinical and Translational Science
|
November 29, 2024
Pharmacokinetics of infigratinib and its active metabolites in Chinese patients with advanced gastric cancer harboring FGFR2 gene amplification
Jiajia Yuan, Lin Shen, Tian Shu Liu, et al.
Journal for Immunotherapy of Cancer
|
February 22, 2023
SAFFRON-103: a phase 1b study of the safety and efficacy of sitravatinib combined with tislelizumab in patients with locally advanced or metastatic non-small cell lung cancer
Jun Zhao, Xinmin Yu, Dingzhi Huang, et al.
Plos One
|
May 23, 2014
Use of metformin alone is not associated with survival outcomes of colorectal cancer cell but AMPK activator AICAR sensitizes anticancer effect of 5-fluorouracil through AMPK activation
Xinbing Sui, Yinghua Xu, Jie Yang, et al.
Cancer
|
May 30, 2025
Tebotelimab plus niraparib in previously treated locally advanced or metastatic solid tumors: A phase 1b dose escalation and expansion study
Miao-Zhen Qiu, Hongming Pan, Ka On Lam, et al.
Translational Oncology
|
April 14, 2019
A Phase Ib Study of Pembrolizumab as Second-Line Therapy for Chinese Patients With Advanced or Metastatic Melanoma (KEYNOTE-151)
Lu Si, Xiaoshi Zhang, Yongqian Shu, et al.
Page
of 27